Cargando…
An ultra-long new onset refractory status epilepticus: Winning the battle but losing the war?
New onset refractory status epilepticus (NORSE), is a rare and challenging condition occurring in previously healthy people. The etiology often remains undiscovered and is frequently associated with an unfavorable outcome. We report the electroclinical and neuroradiological evolution of an ultra-lon...
Autores principales: | Orlandi, Niccolò, Giovannini, Giada, Mirandola, Laura, Monti, Giulia, Marudi, Andrea, Mosca, Francesco, Lalla, Alessandra, d'Orsi, Giuseppe, Francavilla, Matteo, Meletti, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014360/ https://www.ncbi.nlm.nih.gov/pubmed/35445189 http://dx.doi.org/10.1016/j.ebr.2022.100537 |
Ejemplares similares
-
COVID-19: losing battles or winning the war?
por: Reperant, Leslie A., et al.
Publicado: (2020) -
India’s ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?
por: Sulis, Giorgia, et al.
Publicado: (2022) -
Clinical phenotypes within nonconvulsive status epilepticus
por: Lattanzi, Simona, et al.
Publicado: (2021) -
Status epilepticus with prominent motor symptoms clusters into distinct electroclinical phenotypes
por: Lattanzi, Simona, et al.
Publicado: (2021) -
Fungal clones win the battle, but recombination wins the war
por: Drenth, André, et al.
Publicado: (2019)